Cannabis Use in Cancer Patients
Completed
Conditions studied: Solid Tumor, Adult
In brief
The goal of this study is to determine the feasibility of a human observational study of orally administered cannabis use among cancer patients.
Key facts
- Study ID
- NCT03617692
- Run by
- University of Colorado, Denver
- People needed
- 27
- Starts
- 2018-12-04
- Expected to finish
- 2022-12-12
- Last updated by the study team
- 2024-06-11
Who can join
Age: 21 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision to sign and date the consent form.
- Stated willingness to comply with all study procedures and be available for the duration of the study.
- Be a female or male aged at least 21 years.
- Have a diagnosis of any solid tumor type who has or is undergoing either curative or palliative treatment
- Have intent or interest to use cannabis to treat their symptoms.
You may not qualify if…
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Report of other non-prescription drug use, such as cocaine, heroin, methamphetamine in the past 60 days
- Actively seeking or in treatment for any substance use disorder
- Acute illness other than cancer that could affect cognition or compliance per the decision of the study M.D.
- Premenopausal females who are pregnant or trying to become pregnant. Note that pregnancy testing will not be required.
- A Telephone Interview for Cognitive Status (TICS) score indicating moderate or severe cognitive impairment at screening
Where it is running
- University of Colorado Hospital — Aurora, Colorado, United States
- University of Colorado Boulder — Boulder, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.